Altamira Therapeutics Ltd. (CYTOF): 6-K filed Sep 19, 2024

Form type

6-K

Filing date

Sep 19, 2024

Accession number

0001213900-24-080300

Filer

Altamira Therapeutics Ltd. (CIK 1601936)